Research Article

Increased Expression of Long Noncoding RNA LOC100506314 in T cells from Patients with Nonsegmental Vitiligo and Its Contribution to Vitiligo Pathogenesis

Figure 2

Validation of aberrantly expressed mRNA transcripts in T cells from another 41 patients with vitiligo and 41 healthy controls using quantitative polymerase chain reaction. After adjusted for age and sex, T cells from patients with vitiligo remained significantly elevated in the expression levels of Lnc-ARRDC3-1 (1.61-fold; ), PLCG1 (1.37-fold; ), A_33_P3229958 (1.46-fold; ), TERM1 (2.04-fold; ), RAB13 (1.36-fold; ), and LOC100506314 (1.85-fold; ), and decreased in the expression levels of TM4SF19 (0.38-fold; ), IFI27 (0.43-fold; ), and IL17RB (0.70-fold; ) compared to those in controls. P values were obtained by t-test.